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Intervertebral disc (IVD) degeneration is a common cause of back pain. IVD
begins early in adult life and may progress slowly for decades until becoming
symptomatic and requiring medical intervention. The adult human IVD
seems incapable of intrinsic repair and there are currently no proven
treatments to prevent, stop or even retard disc degeneration. Fusion is
currently the most common surgical treatment of symptomatic disc disease.
However, radiographic follow-up studies have revealed that as many as 80%
of patients may develop adjacent segment disc degeneration due to altered
spine biomechanics. A biological means to treat disc degeneration is
therefore desirable. The purpose of the workshop is to look at recent ad-
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